VANCOUVER, BC, March 14,
2023 /CNW/ - Global decision analytics company,
Copperleaf® Technologies Inc. (TSX: CPLF) ("Copperleaf" or the
"Company"), today announced the selection of its solution by Abbott
Products Operations AG.
Abbott, a global leader in health care, selected Copperleaf
Portfolio™ to enhance its investment planning process—moving
from a manual and reactive approach, focused mainly on operational
and tactical planning, to a streamlined process that considers
long-term strategic planning.
The Copperleaf solution will equip Abbott with data-driven
insights into the condition and recapitalization priority of its
capital and production assets, and improve investment decision
making by leveraging a clear understanding of the associated risks
and benefits.
Abbott will be able to realize a balanced and optimized
allocation of CapEx across its sites by creating the highest-value
investment strategies that respect targets and resource
constraints.
"We are looking forward to working with Abbott and thank them
for trusting us with this important project," commented Fin
Jennrich, Regional Director for Copperleaf in Central Europe. "Copperleaf
Portfolio will enable Abbott to make better and more consistent
investment decisions based on an efficient and streamlined
investment planning process."
"We are thrilled to welcome Abbott to the Copperleaf Community
as our first client in the pharmaceutical industry," said
Stefan Sadnicki, Managing
Director for Copperleaf in Europe,
Middle East, and Africa (EMEA). "Our solution will enable
Abbott to assess and compare investments on a common economic scale
to ensure that resources are allocated in the best possible way to
meet strategic goals."
Forward-Looking
Statements
This news release may contain "forward-looking information" and
"forward-looking statements" (collectively, "forward-looking
information") within the meaning of applicable securities laws in
Canada, including, without
limitation, statements with respect to our expectations, future
plans or opportunities. Forward-looking information is necessarily
based on a number of opinions, estimates and assumptions that we
considered appropriate and reasonable as at the date such
statements are made, but which are subject to known and unknown
risks, uncertainties, assumptions and other factors that may cause
the actual results, level of activity, performance or achievements
to be materially different from those expressed or implied by such
forward-looking information, including but not limited to the risk
factors described in our 2021 Annual Information Form ("AIF") under
"Risk Factors. Accordingly, readers should not place undue reliance
on forward-looking information.
These statements reflect the Company's current expectations
regarding future events, performance, and results and speak only as
of the date of this news release. Consequently, there can be no
assurances that such statements will prove to be accurate and
actual results and future events could differ materially from those
anticipated in such statements. Except as required by securities
disclosure laws and regulations applicable to the Company, the
Company undertakes no obligation to update these forward-looking
statements if the Company's expectations regarding future events,
performance, or results change.
About Abbott
Abbott is a global healthcare leader that helps people live more
fully at all stages of life. The company's portfolio of
life-changing technologies spans the spectrum of healthcare, with
leading businesses and products in diagnostics, medical devices,
nutritionals and branded generic medicines. Abbott's 115,000
colleagues serve people in more than 160 countries.
About Copperleaf
Copperleaf (TSX:CPLF) provides enterprise decision analytics
software solutions to companies managing critical infrastructure.
We leverage operational and financial data to empower our clients
to make investment decisions that deliver the highest business
value. What sets us apart is our commitment to providing
extraordinary experiences, shaped by people who care deeply,
products that deliver exceptional value, and partnerships that
stand the test of time. Copperleaf is a patron of The Institute of
Asset Management and actively participates in shaping the future of
asset management standards, including ISO 55000. Headquartered in
Vancouver, Canada, our solutions
are distributed and supported by regional staff and partners
worldwide. Together, we are transforming how the world sees
value.
Source: Copperleaf Technologies Inc. CPLF-IR
SOURCE CopperLeaf Technologies Inc.